Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest
Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest
复制标题
金丝桃苷和let-7a-5p通过诱导G1/S期阻滞协同抑制肺癌细胞增殖
DOI:
10.1016/j.gene.2018.09.011
复制
发表时间:
2018-12-30
期刊:
影响因子:
3.5
通讯作者:
Zhang, Tong-Cun
中科院分区:
文献类型:
--
作者:
Li, Jia-Peng;Liao, Xing-Hua;Zhang, Tong-Cun
Lung cancer remains one of the most aggressive human malignancies with a low survival rate. Hyperoside (quercetin 3-O-beta-D-galactopyranoside) is a flavonol glycoside with an anti-cancer activity. The microRNA-let-7 was widely regarded as a tumor suppressor in human tumors. Here, we investigated the role of hyperoside and let-7a-5p on the lung cancer cell proliferation, cell cycle and apoptosis in A549 cells in vitro. Our results showed that hyperoside could inhibit the proliferation of A549 cells through inducing apoptosis and G1/S phase arrest. Let-7a-5p could inhibit the proliferation of A549 cells via inhibiting the process of G1/S phase. Additionally, hyperoside and let-7a-5p had a synergetic effect on suppressing the proliferation of A549 cells; microRNA-let-7a-5p directly regulated the expression of CCND1 in A549 cells. Our study illustrated that hyperoside and microRNA-let7a-5p might provide a synergistic effect on anti-cancer, which may provide a new idea for lung cancer treatment.